Personal View
The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease

https://doi.org/10.1016/S1473-3099(13)70107-5Get rights and content

Summary

Bacteria constitute about 90% of all cells in the human body. The densest and most complex bacterial community is in the large intestine. This population is quite stable in healthy intestines, but intestinal disease distorts the ecological balance and induces dysbiosis. Results of studies have indicated that the epithelial and metabolic changes that occur with colorectal cancer provide a competitive advantage to a subset of intestinal bacteria. Strikingly, however, Streptococcus gallolyticus gallolyticus (previously known as Streptococcus bovis biotype I) is one of the very few opportunistic pathogens that has been clinically linked to colonic malignant diseases. In this Personal View we describe how S gallolyticus gallolyticus exploits its unique range of virulence features to cause infections in patients with colorectal cancer. We postulate that distinct virulence factors on one hand enable this bacterium to establish a symptomatic infection in susceptible individuals, and on the other hand make its ability to do this dependent on pre-existing colonic abnormalities. We believe that our current reconstruction of this route of infection aids understanding of how S gallolyticus gallolyticus infections can be best exploited for early detection of colorectal cancer.

Introduction

Colorectal cancer is a disease that is typical of developed countries and the fourth most commonly diagnosed cancer in the world, with more than 1 million new cases and more than 600 000 resultant deaths every year.1 Colorectal cancer is initiated by the mutation of stem cells at the base of the crypt,2 and generally arises from polyps that evolve into cancer by the accumulation of mutations. As for most other cancers, the development of colorectal cancer is a result of combined genetic and environmental factors. In particular, consumption of red meat, animal fat, and processed meat increases the risk of colorectal cancer, whereas consumption of calcium, vitamin D, fish, and fibre are thought to reduce the risk.3, 4, 5, 6 Intestinal microbiota might also have a pivotal role in the risk for colorectal cancer, as shown by its inflammatory component, which largely affects the increased risk in patients with inflammatory bowel disease.7, 8

Besides a presumed causative association between the intestinal microbiota and colorectal cancer, disease progression itself also affects the local microbial population.9, 10 The physiological changes that accompany colorectal cancer development, such as altered mucus production and increased epithelial permeability, result in the increased bacterial infiltration of a subset of intestinal bacteria. Specific opportunistic gut pathogens can benefit from the presence of a tumour and use these neoplastic sites as a point of entry to cause systemic infections.10 The best-known bacterium that is associated with colorectal cancer is Streptococcus bovis, infections of which have long been recognised as signs for occult carcinomas of the colon. In this Personal View we give our opinion on how this bacterium establishes infections in patients with colorectal cancer by presenting a reconstruction of its presumed route of infection, inspired by insights into determinants that set the specific connection between particular S bovis subspecies and the disease.

Section snippets

Streptococcus bovis and colorectal cancer

In the 1950s, a remarkable association of an enterococcal infection of the heart valve with underlying occult malignant disease was reported.11 Our systematic review12 of 31 studies published between 1970 and 2010 showed that 65% of the patients infected with S bovis, who mostly had endocarditis, had concomitant colorectal neoplasia. Such neoplasia encompassed adenomas with neoplastic potential (tubular, tubulovillous, and villous adenomas) and carcinomas. Importantly, the rates of neoplasia

Clinical association of Streptococcus gallolyticus gallolyticus and colorectal cancer

Not all S bovis subspecies have a close association with underlying colorectal neoplasia. S bovis belongs to Group D streptococci and can be subdivided into the three known S bovis biotypes: I, II/1, and II/2. In an attempt to modernise and harmonise molecular classification of S bovis subspecies, Schlegel and colleagues14 proposed that these biotypes be reclassified on the basis of molecular characteristics as Streptococcus gallolyticus subsp gallolyticus (I), Streptococcus infantarius subsp

Entry of the human gastrointestinal tract

S bovis species belonging to the S bovis/equinus complex are general gut microbes in several animal hosts.22, 23, 24 S bovis has been isolated from faeces of ruminants (sheep, cows, goats), birds (pigeons), marsupials (koalas, kangaroos, possums), and other animals (pigs, horses, guinea pigs, dogs). S bovis causes disease in several of these hosts, such as mastitis in cattle and septicaemia in pigeons, most often caused by S gallolyticus gallolyticus.23, 25, 26 Results of a study of S

Abundance in the human intestine and colonisation of colorectal cancer tissue

S bovis is one of the predominant species in the ileum of the human intestine,30 and is an important carbohydrate consumer.31 This role is shown by enhancement in functions related to carbohydrate metabolism in the genome of S gallolyticus gallolyticus.32 In healthy people, the faecal carriage of S bovis is generally low (0–10%), but is increased by roughly three to five times in patients with colorectal neoplasia and inflammatory bowel disease, a disease that confers increased risk for

Survival in the colorectal cancer microenvironment

Although available data are not conclusive, results of most studies indicate a preferred colonisation of cancerous tissue by S gallolyticus gallolyticus. We believe that S gallolyticus gallolyticus cells that are shed from the ileum are outcompeted by the resident colonic microbiota in the nutrient-poor environment of the large intestine in a healthy situation. The subsequent disappearance of the bacterium from this ecosystem is shown by the low faecal carriage and colonic mucosal colonisation

Tumour-promoting properties

When S gallolyticus gallolyticus colonises adenomatous or cancerous tissue, it might also contribute to colon tumorigenesis. For example, the suggestion has been made that S gallolyticus gallolyticus and S infantarius infantarius might promote tumour progression by induction of the proinflammatory cyclo-oxygenase-2 (COX-2) pathway.41, 45 Notably, COX-2 is one of the key players in colon carcinogenesis via promotion of cell proliferation, inhibition of apoptosis, and increase in angiogenesis.46,

Translocation across the bowel wall

The fact that S gallolyticus gallolyticus infections are associated with colorectal neoplasia suggests that it needs a distorted epithelium to cross the bowel wall. Results of in-vitro studies showed that it cannot invade intestinal epithelial cells; however, it can translocate across a differentiated monolayer via a paracellular mechanism with a substantially higher translocation efficiency than other S bovis biotypes.53 Because colorectal cancer is characterised by a reduced barrier function,

Establishment of endocarditis

Not all patients with colorectal cancer acquire S gallolyticus gallolyticus infections—the co-occurrence of the cancer and this infection is less than 1%. More than 50% of the patients with S bovis infections have an immunosuppressive condition or underlying heart valve disease, and are thus more susceptible to infections by this opportunistic pathogen.18, 60 However, as clearly shown by the serendipitous identification of S gallolyticus gallolyticus in the blood of healthy blood donors with

S gallolyticus gallolyticus in the early detection of colorectal cancer

The pathway to S gallolyticus gallolyticus infection in patients with colorectal cancer implies that these infections can occur quite commonly without symptoms. This notion has been the incentive to investigate whether a humoral immune response to subclinical S bovis infections could aid early detection of colorectal cancer. Multiple studies have shown that serum IgG concentrations against S bovis antigens could distinguish individuals with both adenomas and carcinomas from healthy controls,67,

Conclusions and future perspectives

The most important insight is that S bovis species should no longer be regarded as a single bacterial entity, because the different S bovis subspecies seem to have different associations with gastrointestinal pathology. We postulate that S gallolyticus gallolyticus (S bovis biotype I) has an unambiguous association with colorectal neoplasia.

Several virulence features of this bacterium are important mediators of the association with such neoplasia, such as the ability to proliferate tumour cell

References (75)

  • RK Yantiss et al.

    Hyperplastic polyp with epithelial misplacement (inverted hyperplastic polyp): a clinicopathologic and immunohistochemical study of 19 cases

    Mod Pathol

    (2001)
  • MD Haimowitz et al.

    A blood donor with bacteraemia

    Lancet

    (2005)
  • K Hirota et al.

    Cross-reactivity between human sialyl Lewis(x) oligosaccharide and common causative oral bacteria of infective endocarditis

    FEMS Immunol Med Microbiol

    (1995)
  • K Hirota et al.

    Highly expressed human sialyl Lewisx antigen on cell surface of streptococcus gallolyticus

    Lancet

    (1996)
  • A Jemal et al.

    Cancer Statistics, 2009

    Cancer J Clinic

    (2009)
  • N Barker et al.

    Crypt stem cells as the cells-of-origin of intestinal cancer

    Nature

    (2009)
  • WC Willett et al.

    Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women

    N Engl J Med

    (1990)
  • T Norat et al.

    Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition

    J Natl Cancer Inst

    (2005)
  • A Boleij et al.

    Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer

    Biol Rev Camb Philos Soc

    (2012)
  • A Hirayama et al.

    Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry

    Cancer Res

    (2009)
  • H Tjalsma et al.

    A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects

    Nat Rev Microbiol

    (2012)
  • W McCoy et al.

    Enterococcal endocarditis associated with carcinoma of the sigmoid; report of a case

    J Med Assoc State Ala

    (1951)
  • A Boleij et al.

    Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis

    Clin Infect Dis

    (2011)
  • E Durante-Mangoni et al.

    Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study

    Arch Intern Med

    (2008)
  • L Schlegel et al.

    Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov

    Int J Syst Evol Microbiol

    (2003)
  • M Beck et al.

    Comprehensive study on strains previously designated Streptococcus “bovis” consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli

    J Clin Microbiol

    (2008)
  • L Schlegel et al.

    Streptococcus infantarius sp. nov., Streptococcus infantarius subsp. infantarius subsp. nov. and Streptococcus infantarius subsp. coli subsp. nov., isolated from humans and food

    Int J Syst Evol Microbiol

    (2000)
  • L Schlegel et al.

    New group D streptococcal species

    Indian J Med Res

    (2004)
  • J Corredoira-Sanchez et al.

    Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study

    Clin Infect Dis

    (2012)
  • KL Ruoff et al.

    Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates

    J Clin Microbiol

    (1989)
  • J Corredoira et al.

    Association between Streptococcus infantarius (formerly S bovis II/1) bacteremia and noncolonic cancer

    J Clin Microbiol

    (2008)
  • H Tjalsma et al.

    Subtyping of Streptococcus bovis group bacteria is needed to fully understand the clinical value of Streptococcus gallolyticus (S. bovis biotype I) infection as early sign of colonic malignancy

    Int J Clin Pract

    (2012)
  • R Osawa

    Tannin-protein complex-degrading enterobacteria isolated from the alimentary tracts of koalas and a selective medium for their enumeration

    Appl Environ Microbiol

    (1992)
  • LA Devriese et al.

    Differentiation between Streptococcus gallolyticus strains of human clinical and veterinary origins and Streptococcus bovis strains from the intestinal tracts of ruminants

    J Clin Microbiol

    (1998)
  • E Sasaki et al.

    ARDRA and RAPD analyses of human and animal isolates of Streptococcus gallolyticus

    J Vet Med Sci

    (2004)
  • R Osawa et al.

    Novel observations of genotypic and metabolic characteristics of three subspecies of Streptococcus gallolyticus

    J Clin Microbiol

    (2004)
  • C Danne et al.

    Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis

    J Infect Dis

    (2011)

    • Cited by (0)

    View full text
    Copyright © 2013 Elsevier Ltd. All rights reserved.